Granted, this is actually a trial in humans, so that's good! But if you look at the study, the focus is on detecting circulating cancer cells; attempting to use the technology to destroy them is relegated to one paragraph near the end. There they note that this seemed to happen by accident, to a limited degree, in 6 out of the 18 patients; so they tried again in a single patient, whose melanoma cell melanin content was particularly favorable for this process, and it again seemed to work ("up to a 48-fold reduction" in circulating melanoma cells.)
They went on to do in vitro tests to try and show it would work in general, aiming the laser at a test tube full of blood; this worked, which is encouraging, but it shouldn't be taken as a strong indicator of anything practical. (And even there, they note that the melanin content of the tumor cells is important to the treatment's effectiveness.)
And yes, it's only targeting circulating melanoma cells. This tech can't just aim a laser at a tumor and kill it; it probably isn't useful for non-solid cancers like leukemia, either. So while this is cool and interesting, it's not a huge breakthrough in cancer treatment.